CMCER

Canadian Medical Center Co.

4021StocksTadawulHealthcare

Financials

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Ratios

1-5

	CurrentMar 10, 2026	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022
Market & Price
Market Capitalization	427.35M	470.47M	542.85M	449.68M	346.50M
Market Cap Growth	-12.6%	-13.3%	+20.7%	+29.8%	-48.0%
Enterprise Value	399.05M	442.69M	504.98M	398.12M	290.36M
Last Close Price	5.55	6.11	6.96	5.69	4.33
Valuation Multiples
PE Ratio	40.71	44.82	52.86	28.62	22.14
PS Ratio	2.88	3.17	4.90	4.48	4.27
PB Ratio	4.45	4.90	5.78	4.90	3.98
P/TBV Ratio	4.45	4.90	5.78	4.90	3.98
P/FCF Ratio	40.63	44.73	—	47.88	21.09
P/OCF Ratio	21.50	23.67	131.32	35.23	20.96
EV/Sales Ratio	2.69	2.99	4.56	3.97	3.58
EV/EBITDA Ratio	16.41	20.50	37.60	24.16	15.27
EV/EBIT Ratio	22.41	24.86	44.19	25.58	16.99
EV/FCF Ratio	37.94	42.09	—	42.39	17.67
Leverage & Capital
Debt / Equity Ratio	0.06	0.06	0.08	0.05	0.06
Debt / EBITDA Ratio	0.25	0.25	0.47	0.25	0.26
Debt / FCF Ratio	0.57	0.57	—	0.47	0.32
Net Debt / Equity Ratio	-0.30	-0.30	-0.35	-0.53	-0.59
Net Debt / EBITDA Ratio	-1.31	-1.31	-2.41	-2.97	-2.70
Net Debt / FCF Ratio	-2.69	-2.69	8.32	-5.22	-3.13
Efficiency & Liquidity
Asset Turnover	1.17	1.17	0.96	0.91	0.72
Inventory Turnover	33.41	33.41	21.80	15.82	17.35
Quick Ratio	3.62	3.62	5.60	7.86	8.36
Current Ratio	4.00	4.00	6.57	8.67	8.97
Returns & Yields
Return on Equity (ROE)	+11.1%	+11.1%	+11.1%	+17.6%	+17.3%
Return on Assets (ROA)	+8.8%	+8.8%	+6.2%	+8.8%	+9.5%
Return on Invested Capital (ROIC)	+21.7%	+23.1%	+17.5%	+34.9%	+41.4%
Return on Capital Employed (ROCE)	+16.6%	+16.6%	+10.9%	+15.4%	+17.4%
Earnings Yield	+2.5%	+2.2%	+1.9%	+3.5%	+4.5%
FCF Yield	+2.5%	+2.2%	-0.7%	+2.1%	+4.7%
Dividend Yield	+2.9%	+2.1%	+0.7%	+3.3%	+4.6%
Payout Ratio	+73.4%	+73.4%	+67.5%	+73.5%	+147.6%
Buyback Yield / Dilution	—	—	—	—	—
Total Shareholder Return	+2.9%	+2.1%	+0.7%	+3.3%	+4.6%

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Ratios

1-5

	CurrentMar 10, 2026	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022
Market & Price
Market Capitalization	427.35M	470.47M	542.85M	449.68M	346.50M
Market Cap Growth	-12.6%	-13.3%	+20.7%	+29.8%	-48.0%
Enterprise Value	399.05M	442.69M	504.98M	398.12M	290.36M
Last Close Price	5.55	6.11	6.96	5.69	4.33
Valuation Multiples
PE Ratio	40.71	44.82	52.86	28.62	22.14
PS Ratio	2.88	3.17	4.90	4.48	4.27
PB Ratio	4.45	4.90	5.78	4.90	3.98
P/TBV Ratio	4.45	4.90	5.78	4.90	3.98
P/FCF Ratio	40.63	44.73	—	47.88	21.09
P/OCF Ratio	21.50	23.67	131.32	35.23	20.96
EV/Sales Ratio	2.69	2.99	4.56	3.97	3.58
EV/EBITDA Ratio	16.41	20.50	37.60	24.16	15.27
EV/EBIT Ratio	22.41	24.86	44.19	25.58	16.99
EV/FCF Ratio	37.94	42.09	—	42.39	17.67
Leverage & Capital
Debt / Equity Ratio	0.06	0.06	0.08	0.05	0.06
Debt / EBITDA Ratio	0.25	0.25	0.47	0.25	0.26
Debt / FCF Ratio	0.57	0.57	—	0.47	0.32
Net Debt / Equity Ratio	-0.30	-0.30	-0.35	-0.53	-0.59
Net Debt / EBITDA Ratio	-1.31	-1.31	-2.41	-2.97	-2.70
Net Debt / FCF Ratio	-2.69	-2.69	8.32	-5.22	-3.13
Efficiency & Liquidity
Asset Turnover	1.17	1.17	0.96	0.91	0.72
Inventory Turnover	33.41	33.41	21.80	15.82	17.35
Quick Ratio	3.62	3.62	5.60	7.86	8.36
Current Ratio	4.00	4.00	6.57	8.67	8.97
Returns & Yields
Return on Equity (ROE)	+11.1%	+11.1%	+11.1%	+17.6%	+17.3%
Return on Assets (ROA)	+8.8%	+8.8%	+6.2%	+8.8%	+9.5%
Return on Invested Capital (ROIC)	+21.7%	+23.1%	+17.5%	+34.9%	+41.4%
Return on Capital Employed (ROCE)	+16.6%	+16.6%	+10.9%	+15.4%	+17.4%
Earnings Yield	+2.5%	+2.2%	+1.9%	+3.5%	+4.5%
FCF Yield	+2.5%	+2.2%	-0.7%	+2.1%	+4.7%
Dividend Yield	+2.9%	+2.1%	+0.7%	+3.3%	+4.6%
Payout Ratio	+73.4%	+73.4%	+67.5%	+73.5%	+147.6%
Buyback Yield / Dilution	—	—	—	—	—
Total Shareholder Return	+2.9%	+2.1%	+0.7%	+3.3%	+4.6%